A new study reveals that treating people with MODY with some Type 2 treatments can curb natural insulin production.
A beginning comparison between two artificial pancreas systems.
It’s part of the company’s effort to retool after taking back control of the drug from Sanofi.
A new study finds it’s bad for you. But you knew that already, didn’t you?
The FDA fast-tracks a treatment that would, in theory, use T cells to stop Type 1 diabetes in its tracks
A trial participant shares her experience, and her hope for the experimental system’s success.
The company plans to submit the pump system for FDA approval in 2017.
German researchers test whether such screening leads to better health outcomes for children with Type 1 and their parents.
Parent-to-parent mentoring may help parents provide improved care to children recently diagnosed with Type 1 diabetes.
Newsflash – diabetes is expensive. (Sigh.)
In a new study, researchers suggest that better sanitation and hygiene standards might be the culprit.
He is the second patient to be successfully treated by the experimental treatment, which was invented by the Diabetes Research Institute.
Researchers find they are three times more likely to develop the condition than the average population.
A recent study found that people with celiac disease and Type 1 diabetes have a higher risk of developing autoimmune thyroid disease.
The popular Type 2 medication is already being used off-label as an add-on to insulin therapy.
A new study suggests nearly 90 percent of teens with Type 1 could use more Vitamin D.
In a major trial, researchers are attempting to keep beta cells working longer in children at risk of Type 1 diabetes.
Researchers at the Diabetes Research Institute announce animal trial results that suggest cells outside of the pancreas can produce insulin.
Do well-publicized research efforts overshadow more worthy research efforts?
It performed nearly as well as injectable glucagon in staving off hypoglycemia.